FDA Issues New Recommendations for Use of Artificial Intelligence to Support Regulatory Actions

Posted on by admin

Guidance marks the regulatory body’s first on artificial intelligence applications in drug and biological product development.

Leave a Reply

Your email address will not be published. Required fields are marked *